In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
3 days 43 min ago
1 week 3 days ago
2 weeks 6 days ago
5 weeks 2 days ago
9 weeks 2 days ago
9 weeks 3 days ago
13 weeks 19 hours ago
13 weeks 19 hours ago
22 weeks 5 hours ago
30 weeks 6 days ago